| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |